Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huabo Wang

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Bioorganic Chemistry|December 15, 2024
Design, synthesis and biological evaluation of novel pyrazolinone derivatives as multifunctional ligands for the treatment of Alzheimer's diseaseHuabo Wang, Yulu Wu, Anran Liu, et al.
The American Journal of Pathology|January 31, 2025
Gas1-Mediated Suppression of Hepatoblastoma TumorigenesisKeyao Chen, Huabo Wang, Bingwei Ma, et al.
Molecular Cancer Therapeutics|September 19, 2007
Improved low molecular weight Myc-Max inhibitorsHuabo Wang, Dalia I Hammoudeh, Ariele Viacava Follis, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Pharmacophore identification of c-Myc inhibitor 10074-G5Jeremy L Yap, Huabo Wang, Angela Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Body-Wide Inactivation of the Myc-Like Mlx Transcription Factor Network Accelerates Aging and Increases the Lifetime Cancer IncidenceHuabo Wang, Taylor Stevens, Jie Lu, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
The Myc-Like Mlx Network Impacts Aging and MetabolismHuabo Wang, Taylor Stevens, Jie Lu, et al.
BMC Cancer|July 14, 2019
Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancersJordan Mandel, Huabo Wang, Daniel P Normolle, et al.
The Journal of Biological Chemistry|February 14, 2019
Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblastsHuabo Wang, Jie Lu, Sucheta Kulkarni, et al.
Plos One|June 27, 2019
Inhibition of hepatocellular carcinoma by metabolic normalizationHuabo Wang, Jie Lu, James Dolezal, et al.
Journal of Medicinal Chemistry|February 14, 2009
Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore modelGabriela Mustata, Ariele Viacava Follis, Dalia I Hammoudeh, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Bioorganic Chemistry|December 15, 2024
Design, synthesis and biological evaluation of novel pyrazolinone derivatives as multifunctional ligands for the treatment of Alzheimer's diseaseHuabo Wang, Yulu Wu, Anran Liu, et al.
The American Journal of Pathology|January 31, 2025
Gas1-Mediated Suppression of Hepatoblastoma TumorigenesisKeyao Chen, Huabo Wang, Bingwei Ma, et al.
Molecular Cancer Therapeutics|September 19, 2007
Improved low molecular weight Myc-Max inhibitorsHuabo Wang, Dalia I Hammoudeh, Ariele Viacava Follis, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2012
Pharmacophore identification of c-Myc inhibitor 10074-G5Jeremy L Yap, Huabo Wang, Angela Hu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Body-Wide Inactivation of the Myc-Like Mlx Transcription Factor Network Accelerates Aging and Increases the Lifetime Cancer IncidenceHuabo Wang, Taylor Stevens, Jie Lu, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
The Myc-Like Mlx Network Impacts Aging and MetabolismHuabo Wang, Taylor Stevens, Jie Lu, et al.
BMC Cancer|July 14, 2019
Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancersJordan Mandel, Huabo Wang, Daniel P Normolle, et al.
The Journal of Biological Chemistry|February 14, 2019
Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblastsHuabo Wang, Jie Lu, Sucheta Kulkarni, et al.
Plos One|June 27, 2019
Inhibition of hepatocellular carcinoma by metabolic normalizationHuabo Wang, Jie Lu, James Dolezal, et al.
Journal of Medicinal Chemistry|February 14, 2009
Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore modelGabriela Mustata, Ariele Viacava Follis, Dalia I Hammoudeh, et al.
Pageof 5